BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BIO 300 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of BIO 300\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07323732-2395@assetmemo.bio
DTSTAMP:20261121T005829Z
DTSTART;VALUE=DATE:20290106
DTEND;VALUE=DATE:20290107
SUMMARY:BIO 300: Phase 2 readout est. (NCT07323732)
DESCRIPTION:BIO 300\, phase 2\, Non-Small Cell Lung Cancer.\nStudy: A Study
  of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell L
 ung Cancer and Interstitial Lung Disease\nEstimated primary completion: 6 
 January 2029. This is a ClinicalTrials.gov estimate\, not a confirmed read
 out date\, and it can move.\nDrug page: https://assetmemo.bio/drug/bio-300
 #upcoming-events\nRegistry record: https://clinicaltrials.gov/study/NCT073
 23732
URL:https://assetmemo.bio/drug/bio-300#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
